For laboratory research use only. Not for human or veterinary use.Lab research use only. Not for human or animal use.
Peptides studied in cell-migration, angiogenesis and actin-binding research — including BPC-157 and the BPC-157 + TB-500 blend — supplied to laboratories and researchers for in vitro use. Every vial is independently lab-tested before release, with published certificates listed by product and strength in the COA library, stocked in Australia and dispatched the same business day when ordered before 12pm Sydney time. For in vitro research purposes only.
Cell signalling research peptides are short peptide chains studied for how they act on cell migration, blood-vessel formation and the actin cytoskeleton. This category holds BPC-157, TB-500 and the BPC-157 + TB-500 blend, each studied in angiogenesis and cell migration assays, alongside KPV, a tripeptide from the tail of alpha-MSH studied in melanocortin signalling. Each is a freeze-dried research material supplied in Australia for in vitro work.
BPC-157 is a fifteen-amino-acid chain, GEPPPGKPADDAGLV, HPLC-tested, identity-confirmed by mass spectrometry and supplied as freeze-dried white powder sealed in glass and shipped to all states and territories. Its residues match a section of a gastric-juice protein, and laboratory assays describe it binding VEGFR2, a receptor on the cells lining blood vessels. In vitro research purposes only.
The vial holds lyophilised powder covering both chains together. BPC-157 is a fifteen-amino-acid chain, GEPPPGKPADDAGLV, which laboratory tests link to VEGFR2, the receptor that drives new blood-vessel growth; TB-500 is Ac-LKKTETQ, the seven-amino-acid piece of thymosin beta-4 that grips actin. Both are studied in cell-signalling research, and the blend reaches every state and territory by post. In vitro research purposes only.
The contents, independently lab-tested before release, are dried to a solid: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, a seven-amino-acid chain copied from thymosin beta-4 that binds free actin, matching positions 17 to 23 of the 43-residue parent protein. It is studied in cell-migration research as that protein's actin-binding piece and posted to every state and territory. Not for people or animals. In vitro research purposes only.
KPV is a dried, off-white tripeptide in a tamper-sealed vial: lysine, proline and valine, the last three amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied in inflammation research, where laboratories test it against PepT1, the transporter that lets it into cells, and against NF-kappaB and MAP kinase, switches that turn inflammation on. It is independently lab-tested. In vitro research purposes only.
Choose by whether the research question is one mechanism or several. BPC-157 and TB-500 are studied separately and are also listed together as a single blended vial; KPV is a distinct alpha-MSH fragment. Every compound here comes in one strength, so the choice is compound, not size.
| Compound | Vial strengths listed | Studied in relation to |
|---|---|---|
| BPC-157 | 10 mg | angiogenesis and cell migration |
| BPC-157 + TB-500 | 10 mg | cell migration and angiogenesis |
| TB-500 | 10 mg | actin binding and cell migration |
| KPV | 10 mg | inflammation |